Researchers at the National Institutes of Health and their colleagues have found that a toxic protein made by the body called DUX4 may be the cause of two very different rare genetic disorders. For patients who have facioscapulohumeral ...
Feb 17, 2023
0
873
The make-up of the gut microbiome may be linked to a person's risk of developing 'long COVID' many months after initial infection with SARS-CoV-2, the virus responsible for COVID-19 infection, suggests research published ...
Jan 25, 2022
0
381
In the spring of 2019, Peruvian neurologists saw a significant increase in the number of patients with Guillain-Barre syndrome (GBS). This rare disorder occurs when a person's immune system damages the nerves, causing muscle ...
Apr 1, 2021
2
317
Blocking the activity of a single protein in old mice for one month restores mass and strength to the animals' withered muscles and helps them run longer on a treadmill, according to a study by researchers at the Stanford ...
Dec 10, 2020
1
1248
A new study from The Ottawa Hospital and the University of Ottawa is poised to completely change our understanding of Duchenne muscular dystrophy and pave the way for far more effective treatments.
Nov 16, 2015
1
1855
South Africa's medicines regulatory authority says it has recorded two fatal cases of the rare Guillain-Barre syndrome in people who had received a Johnson & Johnson COVID jab.
Sep 13, 2022
0
99
It's rubbed on the skin to reduce signs of aging and consumed by athletes to improve endurance but scientists now have the first evidence of one of vitamin E's normal body functions.
Dec 20, 2011
4
0
Researchers have discovered a new technique that overcomes one of the major challenges of stem cell therapy.
Jan 25, 2018
0
150
A growing collection of anecdotal stories raises the possibility that nerve injury in an arm or a leg can act as a trigger for the development amyotrophic lateral sclerosis, or ALS—a progressive neurodegenerative disease ...
Feb 20, 2019
0
648
(HealthDay)—Multiple sclerosis (MS) is more likely to progress to advanced disease among patients who suffer from fatigue and limited use of their legs, new research suggests.
Mar 1, 2017
0
80
